Biogen image

Alzheimer’s tie-up for Eisai and Biogen

March 6, 2014
Research and Development, Sales and Marketing Alzheimer's, BAN2401, Biogen IDEC, E2609, Eisai

Eisai and Biogen Idec have joined forces to look for new Alzheimer’s treatments, developing and commercialising two of the Japanese …

Smart pill image

Smart pills ‘set to boom’

March 5, 2014
Medical Communications, Research and Development, Sales and Marketing frost and sullivan, rajan, smart pills, smartpills

There will be an explosion in the development of smart pills used for internal imaging and even drug delivery within …

Map image

Twitter useful for tracking HIV outbreaks

March 5, 2014
Medical Communications, Sales and Marketing AIDS, HIV, Twitter, digital, flu, ucla, virus, wells

A study by UCLA researchers has shown that Twitter and social media can be used as a practical real-time tool …

alberto_lledo

Canbex Therapeutics hires chief medical officer



March 5, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canbex Therapeutics

UK biotech firm Canbex Therapeutics has appointed former Lilly head Dr Alberto Lledó as its new chief medical officer (CMO). …

Inlyta image

NICE U-turn on Pfizer drug Inlyta

March 5, 2014
Research and Development, Sales and Marketing Kidney cancer, NHS, NICE, Pfizer, axitinib, inlyta

NICE has recommended that Pfizer’s kidney cancer drug Inlyta should be used for some patients in England, following a similar …

Cobra biologics image

Cobra agrees oncology deal with BioCancell

March 4, 2014
Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology

Contract manufacturing organisation Cobra Biologics has signed a deal with specialist oncology biopharma firm BioCancell to manufacture an investigational cancer …

Clinical trials image

Clinical studies still not being published

March 4, 2014
Research and Development, Sales and Marketing ABPI, EMA, alltrials, clinical trials, csr

Half of all trials registered on a US clinical study database are not being published in public journals. This is …

john_colby_-_cluepoints

CluePoints appoints three heads

March 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cluepoints, colby, polvent, stephenne

Clinical trial data firm CluePoints has announced three new appointments to its global team. John Colby (pictured) and Elizabeth Polvent join …

Soliris image

Alexion ‘concerned’ over NICE draft

March 4, 2014
Sales and Marketing NICE, aHUS, alexia, blood, eculizumab, soliris

Alexion Pharmaceuticals UK has expressed ‘concern’ that NICE has not yet allowed its rare disease treatment Soliris to be formally …

Exploring the Amber™ auto injector

March 4, 2014
Manufacturing and Production amber autoinjector, auto injector, shl group

SHL first introduced the Amber™ auto injector utilizing Pushclick™ technology at the PDA (Parental Drug Association) event in Basel, Switzerland …

Prescribing image

Print adverts’ prescribing info could be axed

March 3, 2014
Medical Communications MHRA, OTC, medicines, prescribing

The UK drugs regulator is proposing new rules that could see pharma update safety information for their medicines online, whilst …

roche_logo_shadow

Roche lung cancer drug fails

March 3, 2014
Research and Development, Sales and Marketing Cancer, MetMAb, NSCLC, Roche, Tarceva, avastin

An independent data monitoring committee has told Roche to halt a study of its experimental lung cancer drug MetMab due …

Baye image

Xarelto lift for Bayer

March 3, 2014
Manufacturing and Production, Sales and Marketing Bayer, Eylea, Stivarga, Xarelto, blood thinner, xofigo

Bayer Group says sales of its blood thinner Xarelto will be higher than it had predicted, with peak annual sales …

Cello image

Cello unifies all its health agencies

March 3, 2014
Medical Communications Cello, Cello Business Sciences, Insight Research Group, Mash Health Group, MedErgy HealthGroup, The MSI Consultancy

The Cello Group has unified all its health-orientated agencies in order to operate under one umbrella brand called Cello Health. …

GSK sign

GSK submits new Promacta licence

March 3, 2014
Sales and Marketing GSK, NICE, Promacta, Revolade, blood, eltrombopag

GlaxoSmithKline is seeking a new licence for its blood disorder drug Promacta in patients with severe aplastic anaemia. Specifically, the …

neil_flash

dna Medical Communications hires MD

March 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dna Medical Communications, neil flash

Neil Flash has joined healthcare agency dna Medical Communications as the managing director for its UK team. Flash joined dna …

Blood pressure image

Look beyond the screen

March 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, cliinical, data, screening, trials

It makes sense, doesn’t it? You have a drug that’s effective for a certain disease, but no patients. What do …

Hunt image

Insurance firms ‘will not be sold records’

March 3, 2014
Sales and Marketing GPs, HSCIC, Hunt, NHS, care data, care.data

The government is to pledge that insurance companies will not be sold patients’ health records via the care.data information sharing …

dh image

Government questions innovation uptake by doctors

February 28, 2014
Medical Communications, Sales and Marketing ABPI, Hunt, NHS, PPRS, UK, doctors

The government has launched a consultation which aims to establish whether doctors are being held back from using innovative treatments, …

Witty image

GSK’s Witty loses bonus over China scandal

February 28, 2014
Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew

GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …

The Gateway to Local Adoption Series

Latest content